MNPR-101-DFO*-89Zr
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for MNPR-101-DFO*-89Zr, covering 2025-05-22 to 2025-05-22. Get the full timeline:
Most recent: Clinical Trial Update: MNPR-101-DFO*-89Zr Expanded Access Program (EAP) for Patients With Solid Tumor Cancer